Diem, Lara; Hoepner, Robert (2022). [Hypogammaglobulinemia and Multiple Sclerosis - An Overlooked Correlation?]. Therapeutische Umschau, 79(6), pp. 285-288. Hogrefe 10.1024/0040-5930/a001362
Full text not available from this repository.Hypogammaglobulinemia and Multiple Sclerosis - An Overlooked Correlation? Abstract. Hypogammaglobulinemias occur in people with multiple sclerosis (MS) without immunotherapy in 8.1% of patients and with immunotherapy (not drug-specific) in up to 26.4% of affected individuals. This is thus significantly higher than the expected incidence in the general population. In MS patients it is also relevant to differentiate between primary and secondary hypogammaglobulinemia. In particular, anti-CD20 therapies are mainly underlying for the secondary forms in MS patients. With this article, we aim to provide a "spotlight" on hypogammaglobulinemia with a focus on the clinical consequence of these phenomena in people with MS.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology |
UniBE Contributor: |
Diem, Lara, Hoepner, Robert |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0040-5930 |
Publisher: |
Hogrefe |
Language: |
German |
Submitter: |
Pubmed Import |
Date Deposited: |
04 Aug 2022 11:24 |
Last Modified: |
05 Dec 2022 16:22 |
Publisher DOI: |
10.1024/0040-5930/a001362 |
PubMed ID: |
35903830 |
URI: |
https://boris.unibe.ch/id/eprint/171653 |
Actions (login required)
 |
Edit item |